PeaceHealth is now offering monoclonal antibody IV therapy in Southwest Washington. This therapy is a promising treatment for patients at risk for severe complications from COVID-19. In Southwest Washington, PeaceHealth will initially provide the treatment at PeaceHealth Memorial Urgent Care at 3400 Main St., Vancouver. Patients must have a provider referral to be eligible for treatment.
“This is the first community monoclonal therapy clinic in all of Southwest Washington,” said Dr. Shaun Harper, chief medical officer of PeaceHealth Medical Group. “Monoclonal antibody therapy has been proven to reduce hospitalizations in about 70 percent of high-risk, COVID-positive patients. The goal of the treatment is to prevent hospitalizations, reduce viral loads and lessen symptom severity. PeaceHealth is committed to providing access to this potentially life-saving therapy to anyone in our community who could benefit.”
Harper said the treatment is not a cure and does not provide long-term immunity against COVID-19. “The best protection against COVID-19 continues to be immunization with our safe and effective vaccines,” Harper added.
Monoclonal antibody therapy received Emergency Use Authorization from the Federal Drug Administration (FDA) in November 2020 for certain groups of non-hospitalized COVID-19 patients. A form of immunotherapy traditionally used for patients with cancer and other diseases, monoclonal antibody treatment has shown to be very effective for patients who have mild to moderate symptoms from COVID-19 but a high risk of complications.
PeaceHealth is offering the combo drug therapy REGEN-COV (Carsirivimab/Imdevimab). Patients receive the antibodies through a 20-minute intravenous infusion followed by an hour of observation.